Review Article

Noncoding RNAs in Steroid-Induced Osteonecrosis of the Femoral Head

Table 2

Functions of the miRNAs in steroid-induced ONFH.

Evaluated miRNA(s)Study typeInvolved cells/in vivo model/clinical samplesTarget(s)PathwayFunctionsDysregulation (up/down)SpeciesReferences

miR-20bIn vivoOsteocytes and ratBMPBMPBlock the angiogenesis in bone tissues, promoting osteocyte apoptosisUpRat[26]

miR-7In vitroOsteoblastsEGFREGFR/AktPromote osteoblast deathUpHuman[56]

miR-217In vitroBMSCsDKK1Promote cell proliferation and osteogenic differentiationDownHuman[27]

miR-27aIn vivo and vitroPreosteoblasts and ratTGF-β and Smad7TGF-β/Smad7Promote osteogenic differentiation and increase proliferationDownHuman and rat[28]
In vivo and vitromBMSCs and ratPPARγ and GREM1PPARγSuppress adipogenesis and enhance osteogenesisDownRat[21]

miR-320In vivo and in vitroHuman ONFH tissue and ratCYP1A2Inhibit the occurrence and development of ONFHDownHuman and rat[29]

miR-206In vitroOsteoblastsPDCD4Decrease cell viability and proliferation, while apoptosis was inducedUpHuman[30]
In vivo and in vitroOsteoblasts and rabbitCx43Wnt/β-cateninInhibit the differentiation of osteoblastsUpRabbit[31]

mir-34aIn vivo and in vitromBMSCs, HUVECs, and ratRunx2BMSCs: Promote osteogenic differentiation and increase proliferation
HUVECs: acute inhibitory effect on angiogenesis in the early stage of steroid-induced ONFH, but it disturbed the normal vascular reparative process in the compensatory phase, which then indirectly aggravates ONFH.
Down in mBMSCs, and up in HUVECsHuman and rat[32]
In vivoRat serumTgif2OPG/RANK/RANKLAlleviate ONFHDownRat[33]
In vitro and in vivomBMSCs and miceCDK4, CDK6, and cyclin D1JAG1/NotchInhibit BMSCs proliferation and osteoblastic differentiationUpMice[34]

miR-181dIn vitrohBMSCsSmad3Smad3Inhibit osteobalsitc differentiation of BMSCsUpHuman[35]

miR-200aIn vitroOsteoblastsKeap1/Nrf2Nrf2Protect osteoblasts from dexDownHuman[36]

miR-146aIn vitroMurine osteoblastsBcl2Bcl2Inhibits proliferation and induce apoptosisUpMurine[37]
In vivoRabbitWntWnt/β-cateninPromote angiogenesis; inhibited the apoptosis of bone cellsUpRabbits[38]

miR-145In vivo and in vitroHuman THP-1 cells and ratOPGOPG/(RANKL)/RANKInhibit osteoclast differentiation and prevent excessive bone resorptionDownHuman and rat[39]

miR-25-5pIn vitroOsteoblastsPKCζAMPKProtect osteoblasts from steroidUpHuman[40]

miR-23a-3pIn vivo and in vitromBMSCs and ratLRP5Inhibit osteogenic differentiationUpRat[41]

miR-708In vivo and in vitrohBMSCsSmad3Smad3Inhibit osteogenic differentiation and enhance adipogenesis differentiationUpHuman[20]

miR-210In vivo and invitroHUVECs and ratactivate the angiogenesisUpHuman and rat[18]

miR-135bIn vitroOsteoblasticPpm1eAMPKProtects osteoblasts from steroidUpHuman[42]

mir-199a-5pIn vivo and introOsteoblasts and ratWntFZD4, WNT2Inhibit cell proliferation in differentiating osteoblastsUpHuman and rat[43]

miR-548d-5pIn vitrohBMSCsPPARγPPARγSuppress steroid-induced adipogenic differentiation of and enhance osteogenic potential.DownHuman[44]

miR-17/20aIn vivo and vitroOsteoblasts and ratRANKLRANKLInhibit steroid-induced osteoclast differentiationDownHuman and rat[45]

Note. miRNAs, microRNAs; ONFH, osteonecrosis of the femoral head; BMSCs, bone marrow mesenchymal stem cells; GREM1, gremlin 1; BMP, bone morphogenesis protein; EGFR, epidermal growth factor receptor; DKK1, dickkopf-related protein 1; TGF-β, transforming growth factor-β; PPARγ, peroxisome proliferator-activated receptor gamma; Runx2, Runt-related transcription factor 2; CYP1A2, cytochrome P450 1A2; PDCD4, programmed cell death protein 4; Cx43, Connexin43; HUVECs, human umbilical vein endothelial cells; Tgif2, transforming growth factor-beta-induced factor homeobox 2; OPG, osteoprotegerin; RANK, Receptor activator of nuclear factor B; RANKL, receptor activator of nuclear factor B ligand; Nrf2, NF-E2-related factor 2; Bcl2, B-cell lymphoma-2; PKCζ, protein kinase C ζ; AMPK, AMP-activated protein kinase; LRP-5, low-density lipoprotein receptor-related protein 5.